For research use only. Not for therapeutic Use.
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma[1].
| Catalog Number | I041566 |
| CAS Number | 2168561-20-2 |
| Purity | ≥95% |
| Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 34, No. 1, 2020. |
